MATERIALS AND METHODS: The isolate was grown in a bioreactor, inactivated using binary ethyleneimine, adjuvanted with Montanide 71VG, and injected into day-old broiler chickens either with or without booster groups. The following parameters were measured: T lymphocyte profile in the liver, spleen, and thymus; FAdV antibody titer; clinical symptoms; gross and histological alterations in the liver, spleen, and thymus; virus copy number in the liver and cloacal shedding.
RESULTS: Compared to the unchallenged control group, booster (BG), and non-booster (NBG), the challenged control group (CCG) had a larger liver: body weight (BW) ratio, milder clinical signs, gross lesions, and histological alterations. They also had a lower BW. At 7, 21, 35, and 42 days post-inoculation (dpi), the NBG and BG exhibited higher antibody levels than the UCG. At 35 dpi, challenged BG and NBG produced more antibodies than CCG. In BG and NBG, T cells were stimulated in the spleen, thymus, and liver. At 35 and 42 dpi, the challenged BG and NBG showed significantly decreased viral copy numbers in the liver and shedding, respectively, along with increased lymphocyte counts.
CONCLUSION: The inactivated UPM11142P5B1 with Montanide 71VG could be a vaccine against FAdV 8b infections in chickens.
SYSTEMATIC REVIEW REGISTRATION: http://www.crd.york.ac.uk/PROSPERO, identifier (ID: CRD42023455192).
METHODS: A cross-sectional study was conducted from April to June 2024 using a questionnaire-based approach. The questionnaire, developed in English, was uploaded to Google Forms and distributed through social networking platforms. It consisted of four sections: demographic information, pharmacists' experiences with gabapentin abusers, strategies to limit access to gabapentin, and perceptions of gabapentin abuse, which were assessed using a 5-point Likert scale. A Chi-square test was employed to analyze the association between categorical variables.
RESULTS: The study included 209 pharmacists (median age 29.0 years, IQR 8.0 years). Concerning gabapentin, 72.7% of pharmacists received requests to sell it in the past 6 months. Of these, about 75.7% encountered suspected gabapentin abusers, noting behavioural changes (95.9%), frequent refill requests (90.4%), and inconsistent medical histories (87.8%) as key indicators. Most suspected abusers were male (81.7%) and aged 21-30 years (74.8%).Common reasons cited by suspected abusers for requesting gabapentin included neuropathic pain (93.0%), low back pain (89.6%), and mood instability (73.0%). Pharmacists perceived an increase in gabapentin abuse (74.5%) and expressed a need for additional training (83.3%). Additionally, 83.7% recognised their pivotal role in identifying and addressing gabapentin abuse. Finally, significant associations were found between working in chain pharmacies and receiving gabapentin requests (χ² = 9.159, p = 0.002).
CONCLUSION: Pharmacists have an important role in detecting gabapentin abuse which necessitates adequate education. Pharmacists have concerns regarding this issue and believe stricter regulations are needed.
OBJECTIVE OF STUDY: The study assessed digital pharmacy applications in India using the Mobile App Rating Scale (MARS) on Android and iOS devices, aiming to evaluate their quality.
METHODS: An investigation examined the digital pharmacy applications in India that were accessible via the Android Market and App Store. The applications were assessed by two researchers using the MARS questionnaire, a tool that evaluates 23 variables categorized into five domains: Engagement, Functionality, Aesthetics, Information, and Subjective Quality. The grading system spanned from one to five for every category.
RESULTS: A Google Play Store and App Store investigation revealed 40 online pharmacy apps in India, with 13 rejected. Seven were non-English language-related apps and seven were not downloaded. Thirteen were chosen and evaluated using the MARS Scale. The MARS demonstrated significant positive associations across its components, namely Engagement, Functionality, Aesthetics, and Information. Specifically, greater levels of user functionality were shown to be indicative of superior app aesthetics and engagement. The mean rating of the 13 apps fell between the range of 3.11 to 4.32 on a 5-point scale.
CONCLUSION: This is the first study to utilize the MARS scale to assess the efficacy of online pharmacy applications in India. This research enhanced the functionality and quality of various online pharmacy applications utilized in India.
METHODS: This was a multicenter cross-sectional study conducted in 10 neurologic clinics located in Tehran, Iran, over 2 years. The sample size was calculated as 189, including 63 migraine and 126 non-migraine patients.
RESULTS: A significant difference was observed in the mean score of the global Pittsburgh Sleep Quality Index (PSQI) between migraine and non-migraine groups (p-value = 0.002), and in the individual components of the PSQI. However, there were no significant differences in the frequency of different types of chronotype (p-value = 0.125, T = 1.541) or OSA risk between the two groups (p-value = 0.568, T = -0.573). The binary logistic regression model showed that the relationship between global PSQI and migraine was significant (p = 0.002).
CONCLUSION: Sleep quality is a problem for elderly migraine sufferers. Meanwhile, certain factors such as chronotype and OSA have no significant relationship with migraine among community-dwelling seniors. Further studies are required to enhance our understanding of this observation.